Cyclophosphamide Injection and Indinavir: Interaction Details

Brand names
Indinavir
Crixivan
Cyclophosphamide Injection
CytoxanNeosarFrindovyx
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Cyclophosphamide Injection and Indinavir interaction:

Share

Share this interaction

Indinavir

Brand name
  • Crixivan

We don't have a drug information page for Indinavir yet. Have a question about Indinavir? Ask a pharmacist, free →

Cyclophosphamide Injection

Brand names
  • Cytoxan
  • Neosar
  • Frindovyx

What Happens When You Take Cyclophosphamide Injection With Indinavir

What can happen when they are taken together (rated Major)

Increased risk of chemotherapy-induced mucositis, , and infection

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When cyclophosphamide is given together with a (PI), levels of cytotoxic may rise and infection, neutropenia, or mucositis may occur more often.1 A possible explanation is that PIs competitively inhibit the -mediated of cyclophosphamide or inhibit the efflux pump.2

In a drug-interaction study of patients with AIDS-related non-Hodgkin lymphoma, the incidence rate of infection and neutropenia was significantly higher with PI-based HAART regimens combined with cyclosporine/docetaxel/etoposide (CDE) than with a PI-sparing HAART regimen combined with CDE. Caution is warranted when cyclophosphamide and a PI are coadministered; patients should be monitored closely for adverse effects associated with cyclophosphamide, or antiretroviral therapy other than a PI may be considered2

The Cyclophosphamide Injection and Indinavir Interaction, Explained

Indinavir (Crixivan) is an HIV medicine, and cyclophosphamide (Cytoxan) is a chemotherapy medicine. When they are used together, studies show people have a higher chance of chemotherapy side effects. These include a low white blood cell count (which makes it harder to fight germs), more infections, and painful sores in the mouth and throat (called mucositis). Indinavir may cause more of the strong, active form of cyclophosphamide to build up in your body.

The good news: your care team knows how to watch for this. They may check your blood counts more closely or adjust your HIV medicines. Keep taking your medicines as prescribed and talk with your pharmacist or doctor about any questions.

Indinavir + cyclophosphamide: increased cyclophosphamide toxicity (major; established evidence; onset unspecified).

  • Mechanism: Not fully defined. Proposed: PI of -mediated cyclophosphamide (indinavir is a ) and/or efflux inhibition, increasing exposure to cytotoxic . Note cyclophosphamide is a activated mainly by and CYP3A4; despite this, clinical data show increased, not reduced, toxicity.
  • Evidence: In AIDS-related NHL, PI-based HAART with CDE chemotherapy showed significantly higher infection and rates than PI-sparing HAART.
  • Management: If is required, use caution and monitor closely for neutropenia, infection, and mucositis (CBC with differential, clinical signs). Consider a non-PI antiretroviral regimen.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Cyclophosphamide Injection and Indinavir Interact

The likely mechanism

Unknown

“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Cyclophosphamide Injection and Indinavir Interaction

This combination can be managed safely with planning. Your care team may:

  • Monitor you more closely during chemotherapy for low blood counts, infections, and mouth sores.
  • Consider a different HIV medicine that does not belong to the group, if that suits your treatment.

What you can do:

  • Keep taking both medicines as prescribed. Do not stop or change anything on your own.
  • Make sure your cancer team and HIV team both know your full medication list.
  • Tell your care team right away about fever, chills, signs of infection, or painful mouth sores.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Cyclophosphamide Injection or Indinavir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Protease inhibitors potentiate chemotherapy-induced neutropenia

    In a drug-interaction study involving patients with newly diagnosed AIDS-related non-Hodgkin lymphoma, giving -based (PI-based) HAART together with cyclophosphamide/docetaxel/etoposide (CDE) led to higher rates of chemotherapy-induced infection and than giving PI-sparing HAART with CDE, across 190 total cycles. Grade 3 or 4 infections that required hospitalization occurred in significantly more patients receiving PI-based HAART plus CDE (n=48; 48% vs 25%) than in patients receiving PI-sparing HAART plus CDE regimens (n=142), and a comparable significant difference was observed for Grade 4 neutropenia (54% and 38%). Median neutrophil counts on day 10 and day 14 were significantly lower among patients given PI-based HAART than among those given concomitant PI-sparing HAART during CDE.2

Cyclophosphamide Injection and Indinavir: Common Questions

How serious is the Cyclophosphamide Injection and Indinavir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Cyclophosphamide Injection and Indinavir interaction managed?

This combination can be managed safely with planning. Your care team may: Monitor you more closely during chemotherapy for low blood counts, infections, and mouth sores. Consider a different HIV medicine that does not belong to the group, if that suits your treatment. What you can do: Keep taking both medicines as prescribed. Do not stop or change anything on your own. Make sure… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Cyclophosphamide Injection with Indinavir?

The interaction record says a different medicine may be considered in place of one of these two.

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Cyclophosphamide Injection and Indinavir Interaction

Ask in your own words about taking Cyclophosphamide Injection and Indinavir together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: CYCLOPHOSPHAMIDE intravenous injection, oral tablets, cyclophosphamide intravenous injection, oral tablets. Baxter Healthcare Corporation (per FDA), Deerfield, IL, 2013. DailyMed
  2. Bower M, McCall-Peat N, Ryan N, et al: Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood 2004; 104(9):2943-2946. PubMed
Was this write-up helpful?

Other Serious Interactions of Cyclophosphamide Injection and Indinavir

Also serious with Indinavir

Also serious with Cyclophosphamide Injection

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Indinavir

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.